Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paloma Cejas, Ph.D.

Co-Author

This page shows the publications co-authored by Paloma Cejas and Shengqing Gu.
Connection Strength

0.649
  1. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade. Cancer Discov. 2021 Jun; 11(6):1524-1541.
    View in: PubMed
    Score: 0.237
  2. Clonal tracing reveals diverse patterns of response to immune checkpoint blockade. Genome Biol. 2020 10 15; 21(1):263.
    View in: PubMed
    Score: 0.231
  3. In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target. Cell. 2021 Oct 14; 184(21):5357-5374.e22.
    View in: PubMed
    Score: 0.062
  4. CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq Analysis. Genomics Proteomics Bioinformatics. 2021 Jul 17.
    View in: PubMed
    Score: 0.061
  5. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Res. 2021 01 01; 81(1):158-173.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.